Printer Friendly

A.L. LABORATORIES ANNOUNCES FDA APPROVAL FOR LOPERAMIDE ORAL SOLUTION

 A.L. LABORATORIES ANNOUNCES FDA APPROVAL FOR
 LOPERAMIDE ORAL SOLUTION
 FORT LEE, N.J., Sept. 22 /PRNewswire/ -- A.L. Laboratories, Inc. (NYSE: BMD) today announced its liquid pharmaceuticals subsidiary, Barre-National, Inc., has received approval from the Food and Drug Administration (FDA) to manufacture and market Loperamide Hydrochloride Oral Solution, 1 mg/5 mL.
 Loperamide Oral Solution, an anti-diarrheal, will be competitive with the liquid form of Imodium(R) A-D, which has a present market estimated at $20 million. Barre expects to begin marketing Loperamide by year-end.
 A.L. Laboratories is a multinational manufacturer and marketer of specialized value-added, branded pharmaceuticals and animal health micronutrients, with plant sites in Chicago Heights, Illinois; Niagara Falls and Glendale, N.Y.; Baltimore, Maryland; Bellevue, Washington; Copenhagen, Denmark; and Jakarta, Indonesia.
 -0- 9/22/92
 /CONTACT: Iris Daniels of A.L. Laboratories, 201-947-7744, or David Walke or June Filingeri of Morgen-Walke Associates, 212-986-5900, for A.L. Laboratories/
 (BMD) CO: A. L. Laboratories, Inc.; Barre-National, Inc. ST: New Jersey IN: MTC SU:


PS -- NY050 -- 2164 09/22/92 12:04 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Sep 22, 1992
Words:175
Previous Article:TIME WARNER AND ITS N.Y.C. CABLE GROUP BRING SONGS OF MY PEOPLE TO THE MUSEUM OF THE CITY OF NEW YORK; MUSIC VIDEO TO COMPLEMENT EXHIBITION
Next Article:MICHAEL E. NAYLOR JOINS RUBBERMAID
Topics:


Related Articles
PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID
PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE LIQUID
PERRIGO RECEIVES FDA APPROVAL TO MARKET LOPERAMIDE HYDROCHLORIDE CAPLET
WATSON PHARMACEUTICALS ANNOUNCES FDA APPROVAL FOR LOPERAMIDE HYDROCHLORIDE ORAL SOLUTION
A.L. LABORATORIES ANNOUNCES ADDITIONAL APPROVALS FOR ITS ELYZOL DENTALGEL
/C O R R E C T I O N -- A.L. LABORATORIES, INC./
A. L. LABORATORIES ELABORATES ON SECOND QUARTER EARNINGS RELEASE
A. L. LABORATORIES UPDATES IMPACT OF BUSINESS TRENDS ON COMPANY PERFORMANCE
A.L. LABORATORIES ANNOUNCES FDA APPROVAL FOR LOPERAMIDE CAPLETS

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters